Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Pelaez Coyotl 2020 Pharmaceutics

From Bioblast
Publications in the MiPMap
Peláez Coyotl EA, Barrios Palacios J, Muciño G, Moreno-Blas D, Costas M, Montiel Montes T, Diener C, Uribe-Carvajal S, Massieu L, Castro-Obregón S, Espinosa OR, Mata Espinosa D, Barrios-Payan J, León Contreras JC, Corzo G, Hernández-Pando R, Del Rio G (2020) Antimicrobial peptide against Mycobacterium tuberculosis that activates autophagy is an effective treatment for tuberculosis. Pharmaceutics 12:E1071.

» PMID: 33182483 Open Access

Pelaez Coyotl Erika A, Barrios Palacios Jacqueline, Mucino Gabriel, Moreno-Blas Daniel, Costas Miguel, Montiel Montes Teresa, Diener Christian, Uribe-Carvajal Salvador, Massieu Lourdes, Castro-Obregon Susana, Espinosa Octavio Ramos, Mata Espinosa Dulce, Barrios-Payan Jorge, Contreras Juan Carlos Leon, Corzo Gerardo, Hernandez-Pando Rogelio, Del Rio Gabriel (2020) Pharmaceutics

Abstract: Mycobacterium tuberculosis (MTB) is the principal cause of human tuberculosis (TB), which is a serious health problem worldwide. The development of innovative therapeutic modalities to treat TB is mainly due to the emergence of multi drug resistant (MDR) TB. Autophagy is a cell-host defense process. Previous studies have reported that autophagy-activating agents eliminate intracellular MDR MTB. Thus, combining a direct antibiotic activity against circulating bacteria with autophagy activation to eliminate bacteria residing inside cells could treat MDR TB. We show that the synthetic peptide, IP-1 (KFLNRFWHWLQLKPGQPMY), induced autophagy in HEK293T cells and macrophages at a low dose (10 μM), while increasing the dose (50 μM) induced cell death; IP-1 induced the secretion of TNFα in macrophages and killed Mtb at a dose where macrophages are not killed by IP-1. Moreover, IP-1 showed significant therapeutic activity in a mice model of progressive pulmonary TB. In terms of the mechanism of action, IP-1 sequesters ATP in vitro and inside living cells. Thus, IP-1 is the first antimicrobial peptide that eliminates MDR MTB infection by combining four activities: reducing ATP levels, bactericidal activity, autophagy activation, and TNFα secretion. Keywords: Antimicrobial peptide, Autophagy, Iztli peptide, Multidrug resistant, Tuberculosis Bioblast editor: Plangger M O2k-Network Lab: MX Mexico City Uribe-Carvajal S


Labels: MiParea: Respiration, Pharmacology;toxicology  Pathology: Infectious 

Organism: Mouse  Tissue;cell: Fibroblast  Preparation: Intact cells 


Coupling state: ROUTINE, ET 

HRR: Oxygraph-2k 

2020-11